ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001315797

Satter Muneer A

CIK 0001315797 Name as filed on the most recent filing

Filed as Satter Muneer A (53)

105 transaction lines · from 53 filings · filed 2008-04-16 to 2026-05-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

105 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-05-28 Annexon, Inc.
ANNX 		P, Open-market purchase 613,497 acquired 5.41 3,319,018.77 Form 4, filing 0001315797-26-000001
2025-11-21 Annexon, Inc.
ANNX 		P, Open-market purchase 422,613 acquired 4.28 1,808,783.64 Form 4, filing 0001315797-25-000007
2025-11-20 Annexon, Inc.
ANNX 		P, Open-market purchase 400,000 acquired 4.48 1,792,000.00 Form 4, filing 0001315797-25-000007
2025-11-19 Annexon, Inc.
ANNX 		P, Open-market purchase 500,000 acquired 3.94 1,970,000.00 Form 4, filing 0001315797-25-000006
2025-11-18 Annexon, Inc.
ANNX 		P, Open-market purchase 500,000 acquired 3.18 1,590,000.00 Form 4, filing 0001315797-25-000006
2025-11-17 Annexon, Inc.
ANNX 		P, Open-market purchase 500,000 acquired 2.99 1,495,000.00 Form 4, filing 0001315797-25-000006
2023-12-26 Annexon, Inc.
ANNX 		P, Open-market purchase 350,000 acquired 2.88 1,008,000.00 Form 4, filing 0001209191-23-059911
2023-02-10 Annexon, Inc.
ANNX 		P, Open-market purchase 2,647,058 acquired 6.80 17,999,994.40 Form 4, filing 0001567619-23-002932
2022-07-07 Annexon, Inc.
ANNX 		P, Open-market purchase 2,453,988 acquired 3.84 9,423,313.92 Form 4, filing 0001567619-22-013890
2021-01-08 Aileron Therapeutics Inc
ALRN 		P, Open-market purchase 9,000,000 acquired 1.10 9,900,000.00 Form 4, filing 0000899243-21-001163
2020-07-28 Annexon, Inc.
ANNX 		P, Open-market purchase 200,000 acquired 17.00 3,400,000.00 Form 4, filing 0001567619-20-013817
2020-06-08 Aileron Therapeutics Inc
ALRN 		P, Open-market purchase 3,700,000 acquired 1.10 4,070,000.00 Form 4, filing 0000899243-20-015868
2019-01-10 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 23,818 acquired 2.45 58,442.23 Form 4, filing 0000899243-19-000999
2019-01-09 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.39 47,876.00 Form 4, filing 0000899243-19-000999
2019-01-08 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.20 43,972.00 Form 4, filing 0000899243-19-000999
2019-01-07 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.18 43,558.00 Form 4, filing 0000899243-19-000701
2019-01-04 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.12 42,396.00 Form 4, filing 0000899243-19-000701
2019-01-03 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.08 41,508.00 Form 4, filing 0000899243-19-000701
2019-01-02 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 1.94 38,838.00 Form 4, filing 0000899243-19-000196
2018-12-31 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 1.74 34,900.00 Form 4, filing 0000899243-19-000196
2018-12-28 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 1.72 34,372.00 Form 4, filing 0000899243-19-000196
2018-12-27 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 1.67 33,410.00 Form 4, filing 0000899243-18-031908
2018-12-26 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 1.69 33,854.00 Form 4, filing 0000899243-18-031908
2018-12-21 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 1.84 36,870.00 Form 4, filing 0000899243-18-031908
2018-12-20 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 1.85 36,984.00 Form 4, filing 0000899243-18-031493
2018-12-19 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 1.92 38,384.00 Form 4, filing 0000899243-18-031493
2018-12-18 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 1.99 39,856.00 Form 4, filing 0000899243-18-031493
2018-12-14 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.00 40,094.00 Form 4, filing 0000899243-18-031136
2018-12-13 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.02 40,308.00 Form 4, filing 0000899243-18-031136
2018-12-12 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.05 40,938.00 Form 4, filing 0000899243-18-031136
2018-12-11 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.09 41,846.00 Form 4, filing 0000899243-18-030684
2018-12-10 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.13 42,608.00 Form 4, filing 0000899243-18-030684
2018-12-07 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.14 42,788.00 Form 4, filing 0000899243-18-030684
2018-12-06 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.18 43,584.00 Form 4, filing 0000899243-18-030326
2018-12-04 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.10 41,994.00 Form 4, filing 0000899243-18-030326
2018-12-03 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 1.99 39,774.00 Form 4, filing 0000899243-18-030326
2018-11-30 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 1.98 39,692.00 Form 4, filing 0000899243-18-029916
2018-11-29 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 2.01 40,118.00 Form 4, filing 0000899243-18-029916
2018-11-28 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 20,000 acquired 1.94 38,714.00 Form 4, filing 0000899243-18-029916
2018-09-17 Vital Therapies Inc
VTL 		S, Open-market sale 7,044,777 disposed 0.29 2,054,256.97 Form 4, filing 0001280776-18-000089
2018-09-14 Vital Therapies Inc
VTL 		S, Open-market sale 447,500 disposed 0.36 160,384.00 Form 4, filing 0001280776-18-000089
2018-09-13 Vital Therapies Inc
VTL 		S, Open-market sale 3,890,000 disposed 0.50 1,930,996.00 Form 4, filing 0001280776-18-000089
2018-06-28 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 1,818,182 acquired 3.85 7,000,000.70 Form 4, filing 0000899243-18-018724
2018-03-23 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 1,000 acquired 5.00 5,000.00 Form 4, filing 0000899243-18-008446
2018-03-21 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 4,000 acquired 4.85 19,390.00 Form 4, filing 0000899243-18-008446
2018-03-20 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 5,400 acquired 4.97 26,860.14 Form 4, filing 0000899243-18-008259
2018-03-19 Aerpio Pharmaceuticals, Inc.
ARPO 		P, Open-market purchase 7,600 acquired 4.96 37,724.88 Form 4, filing 0000899243-18-008259
2017-12-13 Vital Therapies Inc
VTL 		P, Open-market purchase 50,000 acquired 5.57 278,570.00 Form 4, filing 0001280776-17-000104
2017-12-12 Vital Therapies Inc
VTL 		P, Open-market purchase 50,000 acquired 5.40 269,765.00 Form 4, filing 0001280776-17-000104
2017-12-11 Vital Therapies Inc
VTL 		P, Open-market purchase 50,000 acquired 4.96 248,225.00 Form 4, filing 0001280776-17-000102

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 102
  • Open-market sale 3
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Satter Muneer A, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001315797

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.